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Abstract
Anxiety sensitivity (AS), or the fear/belief that anxiety symptoms and sensations will have
negative outcomes, is a strong predictor of future psychopathology. AS is divided into three
factors: physical, cognitive, and social. Reduced heart rate variability (HRV), or the variation in
intervals between heartbeats, is associated with various psychological disorders. Current research
findings disagree as to whether AS predicts HRV outcomes. The present study sought to
examine data from a previous research project as results of relationships between AS and HRV
were contrary to expectations. The current study examined potential predictors of HRV, such as
the relationship between high-frequency (HF) and low-frequency (LF) HRV, the timing of
administration of the Anxiety Sensitivity Index-3 (ASI-3), gender, and level of AS. HF- and LFHRV were perfectly linearly related, providing support in reporting one index since it can infer
dominant nervous system response in the moment. Furthermore, findings suggested reliability
and internal consistency of the ASI-3 across online and in-person administrations. Gender was
also differentially associated with ASI-3 scores and HRV, but it did not moderate effects
between ASI-3 scores and HRV. Finally, study results provided some support of the Trier Social
Stress Test for the social dimension of AS. A discussion of what variables should be considered
when examining HRV is addressed as well as how current findings relate and add knowledge to
the existing literature regarding the relationship between AS and HRV.

iv
Table of Contents
Acknowledgements ............................................................................................................. ii
Abstract .............................................................................................................................. iii
List of Tables .................................................................................................................... vii
List of Figures .................................................................................................................. viii
Do Gender, Anxiety Sensitivity Level, and Timing of Anxiety Sensitivity Assessment
Predict Heart Rate Variability? ............................................................................... 1
Brief History of the Theories Involving Anxiety Sensitivity.................................. 3
Expectancy Theory ..................................................................................... 4
Emotion Regulation .................................................................................... 4
Distress Tolerance ....................................................................................... 5
Anxiety Sensitivity and Psychopathology .............................................................. 6
Anxiety Sensitivity as a Construct via Behavioral Challenges ............................... 6
Heart Rate Variability ............................................................................................. 7
Heart Rate Variability Measurement and Interpretation ............................. 9
Influences on Heart Rate Variability ........................................................ 11
Clinical Implications of Anxiety Sensitivity and Heart Rate Variability . 11
Heart Rate Variability Used in Challenge Paradigms............................... 12
Anxiety Sensitivity and Heart Rate Variability .................................................... 13
Previous Research on Heart Rate Variability, Anxiety Sensitivity, and Challenge
Paradigms .................................................................................................. 13
Conclusions ........................................................................................................... 16
Study Aims and Hypotheses ................................................................................. 16

v
Method .............................................................................................................................. 18
Measures ............................................................................................................... 18
Demographic Questionnaire ..................................................................... 18
Anxiety Sensitivity Index-3 (ASI-3) ......................................................... 18
Physiological Measurement of Heart Rate Variability (HRV) ................. 18
Procedure .............................................................................................................. 19
Results ............................................................................................................................... 20
Participants ............................................................................................................ 20
Descriptive Statistics ................................................................................. 21
Preliminary Analyses ................................................................................ 23
Hypothesis 1: Are HF- and LF-HRV Perfectly Correlated? ................................. 28
Hypothesis 2: Did Online and In-Person ASI-3 Scores Differ in Relational
Strength to HRV Readings? ...................................................................... 28
Hypothesis 3: Does Gender Moderate ASI-3 Scores and Heart Rate Variability 30
Hypothesis 4: Highest and Lowest Thirds of ASI-3 Scores More Predictive of
HRV? ........................................................................................................ 35
Discussion ......................................................................................................................... 37
Hypothesis 1: Are HF- and LF-HRV Perfectly Correlated? ................................. 37
Hypothesis 2: Did Online and In-Person ASI-3 Scores Differ in Relational
Strength to HRV Readings? ...................................................................... 38
Hypothesis 3: Does Gender Moderate ASI-3 Scores and Heart Rate Variability 40
Hypothesis 4: Highest and Lowest Thirds of ASI-3 Scores More Predictive of
HRV? ........................................................................................................ 42

vi
Limitations ............................................................................................................ 44
Conclusions and Future Directions ....................................................................... 46
References ......................................................................................................................... 47
Appendices ........................................................................................................................ 67
Appendix A: Screening Questionnaire ............................................................................. 68
Appendix B: Demographics Questionnaire ...................................................................... 69
Appendix C: Anxiety Sensitivity Index-3 (ASI-3) ........................................................... 70

vii
List of Tables
Table 1: Demographics for AS Groups ............................................................................ 20
Table 2: Descriptive Statistics for ASI-3 Scores in High, Highest, Normative, and Lowest
AS Groups ............................................................................................................. 22
Table 3: HRV Indices at Baseline and During Behavioral Challenges for High and
Normative AS Groups........................................................................................... 24
Table 4: HRV Indices at Baseline and During Behavioral Challenges for Reported
Gender ................................................................................................................... 24
Table 5: One-Way ANOVA for ASI-3 Scores with Gender as the Predictor .................. 25
Table 6: Paired T-Tests for Baseline HF-HRV to Associated Behavioral Challenge
HF-HRV Readings ................................................................................................ 25
Table 7: Correlations for Online ASI-3 Scores and HRV ................................................ 26
Table 8: Correlations for In-Person ASI-3 Scores and HRV ............................................ 27
Table 9: Fisher’s r-to-z Transformations Between Administrations of ASI-3 in Relation to
HRV for High AS Individuals .............................................................................. 29
Table 10: Fisher’s r-to-z Transformations Between Administrations of ASI-3 in Relation
to HRV for Normative AS Individuals ................................................................. 30
Table 11: Moderation Results with Baseline HF-HRV, ASI-3 Scores, and Gender ........ 31
Table 12: Moderation Results with Physical HF-HRV, ASI-3 Scores, and Gender ........ 32
Table 13: Moderation Results with Cognitive HF-HRV, ASI-3 Scores, and Gender ...... 33
Table 14: Moderation Results with Social HF-HRV, ASI-3 Scores, and Gender ............ 34
Table 15: Fisher’s r-to-z Transformations Between Lowest and Highest ASI-3 Scores
Compared to HRV Readings ................................................................................ 36

viii
List of Figures
Figure 1: Example of an R-R Interval via QRS .................................................................. 8
Figure 2: An Example of a QRS Complex via Electrocardiogram ..................................... 9
Figure 3: Average HF-HRV at Baseline and Each Challenge for Highest and Lowest AS
Groups ................................................................................................................... 35

1
Do Gender, Anxiety Sensitivity Level, and Timing of Anxiety Sensitivity Assessment
Predict Heart Rate Variability?
Anxiety is the most prevalent form of psychopathology experienced (Anxiety and
Depression Association of America, 2018; Kessler et al., 2005). The prevalence of anxiety
makes understanding treatment, prevention, and predictors necessary to help mitigate the effects
experienced by so many. A strong predictor of psychopathology is anxiety sensitivity (AS), or
the fear/belief that anxiety symptoms or sensations will have harmful outcomes (Reiss, 1991).
Previously, AS was thought to be a unidimensional construct, or that specific fear
sensitivities did not have factor or theoretical distinctions that could differ between individuals
(Reiss & McNally, 1985). However, the Anxiety Sensitivity Index-3 (ASI-3) was developed,
which demonstrates three different dimensions of AS. The ASI-3 has strong psychometric
properties across cultures and populations (Kemper et al., 2012; Osman et al., 2010; Taylor et al.,
2007). The three different dimensions the ASI-3 reflects are physical, cognitive, and social
(Taylor et al., 2007). In other words, an individual can have distinct sensitivities within any of
the three categories. However, an individual does not necessarily experience all three. Instead, an
individual could have a sensitivity that better aligns with one factor over the others, suggesting a
targeted fear sensitivity approach could be helpful. Research has attempted to understand if the
latent categories are dimensional or categorical (taxons; Broman-Fulks et al., 2010). Specifically,
researchers have expressed concern with the limited number of social and cognitive items on the
original ASI to reliably assess fear sensitivities (Schmidt et al., 2005; Sandin et al., 2001). Others
have also suggested individual items may measure more than one sensitivity (Taylor et al.,
2007). Additionally, taxons have had minimal support based on these limitations (Bernstein,
Zvolensky, Marshall, et al., 2009; Schmidt et al., 2006), and results have not been replicable
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(Broman-Fulks et al., 2008). These concerns have traveled across each reinvention of the ASI to
its current form (ASI-3; Taylor et al., 2007). Thus, AS is now viewed as a multidimensional
construct, rather than unidimensional or categorical (Asmundson et al., 2011; Bernstein et al.,
2011; Bernstein et al., 2013), and contains three factors. Best practices to test each AS category
have been explored (Bernstein, Zvolensky, Marshall, et al., 2009; Gourley, 2019; Rodriguez et
al., 2004; Waller et al., 1996), but research is severely limited. Further opportunity is available to
explore each factor of AS. Specifically, exploring each factor through potentially anxietyprovoking challenges could be beneficial. This is true not only for further support of the AS
dimensions, but general reactivity to dimensional sensitivities.
One physiological measure of anxiety explored in the literature is heart rate variability
(HRV), or the variation in inter-beat intervals of the heart (Shaffer et al., 2014). HRV will be
discussed in upcoming sections. Research supports HRV as a promising measurement
concerning anxiety. Thus, collecting HRV data while completing tasks related to each factor of
AS could provide valuable knowledge into their relationship with one another. However, it is
known several characteristics and individual differences can affect HRV outside of anxiety
alone. Gender is one such characteristic (Blom et al., 2010; Schmidt, Storey, et al., 2000;
Virtanen et al., 2003).
Previous research and analyses (Gourley, 2019) evidenced AS to potentially not be a
strong indicator of compromised HRV during tasks designed to induce symptoms of AS. Despite
this finding, the general research posits that AS should be a strong indicator of compromised
HRV (Schmidt, Lerew, et al., 2000; Wearne et al., 2019). However, several characteristics that
can influence HRV were not controlled for, which could have influenced these outcomes. The
current study conducted secondary analyses from a previous project (Gourley, 2019) examining
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variables/characteristics that could influence potential relationships between HRV and AS.
Current explorations would be helpful to rectify what variables to consider when evaluating
HRV to reported AS factors.
Brief History of the Theories Involving Anxiety Sensitivity
Foundational research began with Reiss and McNally in 1985, which was when the term
AS came about. AS has been controversial as several researchers did not believe there was a
fundamental difference between AS and trait anxiety (e.g., Lilienfeld et al., 1993). However,
research has developed and demonstrates a difference between AS and trait anxiety today. First,
both AS and trait anxiety have been identified as risk factors for developing anxiety-related
disorders (e.g., Blakey et al., 2017; Deacon & Abramowitz, 2006; Knapp et al., 2016). The
difference lies in the specificity/generalization of how each manifests (McNally, 1985). For
example, AS focuses on targeted fear sensitivities such as innocuous physical sensations. Trait
anxiety focuses on the existence of a stable and generalized disposition to anxiety regardless of
beliefs about physiological sensations (McNally, 1999).
Researchers have tested several models that allow trait anxiety and AS to coexist as
higher- and lower-order factors. Higher-order factors mirror a stable and general disposition to
stressors and anxiety (trait anxiety). Lower-order factors reflect specific beliefs/fears about
physiological sensations experienced, allowing different levels of trait specificity or categorical
dimensions of AS (Lilienfeld et al., 1993). Through these distinguishing factors, AS is viewed as
a facet of trait anxiety, focusing on fears and beliefs about the dangers and harms of anxiety
symptoms (Berman et al., 2010; Plehn & Peterson, 2002; Pollock et al., 2002).
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Expectancy Theory
Expectancy theory is proposed as someone acting or behaving in a certain way because
there is motivation from the expected result of this behavior. For example, someone may avoid
exercise because they expect to have undesirable physiological responses. Expectancy theory is
understood through key fundamental traits concerning AS. Traits include expectations that a
specific outcome will occur when the feared object/situation is engaged (e.g., I will have a panic
attack when hyperventilating), and sensitivities, or “the reasons a person holds for fearing the
anticipated event” (Taylor, 2014, p. 18). An example would be, “I will pass out and have a heart
attack if I have a panic attack.” Expectancy theory focuses on situation-specific elements,
whereas AS is person-specific. These distinctions were a turning point for AS due to the
discussion of AS having three different factors underlying the construct. According to
expectancy theory, three fundamental sensitivities could explain fear, which are fear of
undesirable physiological reactions, fear of anxiety itself, and fear of negative evaluation (Reiss
& McNally, 1985). Expectancy theory also posits that AS itself can later induce panic or panic
symptoms. The higher the sensitivities to stimuli, the more fears people generally have, lending
to the development of psychopathology (Riess, 1991; Taylor et al., 1992). Expectancy theory
concerning AS has its limitations, but it still has important implications for how we view AS and
its dimensionality.
Emotion Regulation
Emotion regulation is another construct with implications for AS. With our current
understanding of the term, emotion regulation is “the process by which individuals influence
which emotions they have, when they have them, and how they experience and express their
feelings. Emotion regulation can be automatic or controlled, conscious or unconscious, and may
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have effects at one or more points in the emotion generative process” (Gross, 1998, p. 275).
Additionally, emotion regulation is acting in desired ways regardless of emotional state. Theories
of anxiety such as AS, panic, and distress tolerance have alluded to a lack of acceptance of
negative emotions. An inability to modify behavior in a heightened emotional state could lend to
emotion dysregulation (Cisler et al., 2010). Consequently, AS may develop from difficulties with
emotion regulation, which could be a predictor of AS (Olatunji et al., 2007).
Distress Tolerance
AS and distress tolerance, or one’s perceived ability to handle emotional distress and
aversive states, are related constructs. Research posits AS and distress tolerance are distinguished
lower-order facets of a connected higher-order affect tolerance and sensitivity factor (Bernstein,
Zvolensky, Vujanovic, et al., 2009). Moreover, distress tolerance is negatively correlated with
anxiety symptomology, indicating the more intolerance to distress, the higher risk for anxietyrelated symptoms (Bernstein et al., 2011; Keough et al., 2010; Timpano et al., 2009). In the same
vein, research has found that AS mediates the relationship between stressful life events and
anxiety symptoms (McLaughlin et al., 2009). Distress tolerance is also connected to emotion
regulation, as the less distress one can tolerate, the less control and acceptance one has over
emotional arousal (McHugh et al., 2013). These findings suggest the connection between
emotion dysregulation, distress intolerance, and AS.
In summary, some theories and constructs have offered conceptualizations related to AS,
and they are essential in understanding the foundation of how we view AS today. However,
fundamental mechanisms behind how we understand the implications of AS are less established.
Overall, it is crucial to explore foundational theories via data collection that effectively predict
AS in various contexts.
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Anxiety Sensitivity and Psychopathology
AS is a vulnerability for several anxiety disorders such as generalized anxiety, obsessions
and compulsions, social anxiety, and panic (Blakey et al., 2017; Deacon & Abramowitz, 2006;
Knapp et al., 2016; Rector et al., 2007; Schmidt et al., 2006; Durdu et al., 2008). AS is also
associated with depression, borderline personality disorder, eating disorders, substance use, and
hoarding (Bernstein et al., 2013; Gratz et al., 2008; Lejuez et al., 2006; Medley et al., 2013;
Taylor, 2014). The strong predictive relationship between AS and future psychopathology may
relate to the core underlying anxiety present in these conditions.
Anxiety Sensitivity as a Construct via Behavioral Challenges
As previously mentioned, AS was once thought to be a unidimensional construct (Reiss
& McNally, 1985), particularly in earlier reiterations of the ASI. However, current research with
the ASI-3 supports three factors: fear of undesirable physiological reactions, fear of cognitive
dyscontrol, and fear of negative evaluation (Taylor et al., 2007). However, the literature has
limitations. For example, it is unclear how social and cognitive domains differ from one another
via measure items (Bernstein et al., 2007; Schmidt et al., 2005). It is also unclear how
distinctions between each factor manifest via behavioral challenges (Castaldo et al., 2015;
Hughes & Stoney, 2000), so it is crucial to assess findings further.
There are behavioral exercises that tap physical, cognitive, and social aspects of anxiety.
For example, hyperventilation has been shown to induce physical anxiety (Carter et al., 2001).
Tasks related to cognitive performance such as the Paced Auditory Serial Addition Task
(PASAT) have mimicked cognitive anxiety (Lejuez et al., 2003). Finally, the Trier Social Stress
Test has been found to induce social anxiety (Wearne et al., 2019). It is less understood what
activities or challenges would be ideal to mimic sensitivities in AS categories and not anxiety

7
generally. Because research in this area is lacking, there is a need to explore each factor with
appropriate behavioral challenges.
Heart Rate Variability
One promising measure of physiological reactivity is HRV, or the variation in the time
interval between heartbeats (Shaffer et al., 2014). Research on the connection between anxiety
and HRV examines the role anxious responding has on increasing physiological arousal in
response to distress. Anxiety is related to emotional arousal, and emotional arousal is associated
with physiological reactivity (Levenson, 2003). Most literature has focused on the autonomic
nervous system (ANS), which plays a significant role in arousal associated with stress. When
someone is physiologically and psychologically stable, arousal is lower. Lower arousal leads to
decreased physiological responses, which is found when less anxiety is present. When increased
physical arousal occurs via an anxious response, sensations are experienced even if they are
inherently non-threatening. Overall, anxiety functions as a possible factor that increases
hypervigilance and exaggerates symptoms, which can be explored through HRV. However, most
research has focused on HRV and anxiety generally. Research would benefit from an exploration
of how AS connects to HRV.
Previous research depicted regular heart rhythms as an indication of optimal heart health.
However, research has since shown that optimal functioning is a consequence of complex
interactions with the cardiac system through highly irregular and variable heart rhythms. HRV
reflects the heart’s ability to change by detecting and quickly responding to unpredictable stimuli
(Acharya et al., 2006). Research has also shown HRV to be a consistent index of current or
future psychopathology if compromised (Adolph et al., 2018; Appelhans & Lueken, 2006;
Batselé et al., 2019).
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Primary roles in understanding HRV on physiology are the ANS and ANS regulation by
the central autonomic network (CAN). The sympathetic nervous system (SNS) and
parasympathetic nervous system (PNS) branches of the ANS control one’s heart rate, leading to
dual innervations of the PNS and SNS on the ANS. More variability (or parasympathetic
response) in the time between heartbeats is reflected as higher HRV, whereas less variability
reflects lower HRV (proposed sympathetic response; Berntson et al., 1997). R-R intervals
measure variable differences across time, which is the amount of time between consecutive
heartbeats. R-R intervals are the peak of a heartbeat (see Figure 1). The activation produced by
both autonomic branches occurs at different frequencies or frequency-based HRV analyses,
described in later sections.
Figure 1
Example of an R-R Interval via QRS Complex

Note. From “CEUfast.com: EKG, ECG Interpretation,” by CEUfast, 2016,
(https://ceufast.com/course/ecg-interpretation).
Key concepts that mirror the SNS and PNS are the fight or flight response, or bodily
reactions to the environment at any given moment. SNS represents one’s reaction to a real or
imagined threat and the need to fight or leave the situation. This reaction typically shuts down
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the body’s primary functions to survive long-term, such as digestion, to focus on survival
necessities such as increased heart rate and pupil dilation. The PNS, however, operates when one
is in a place of safety and the body returns to its pre-threat relaxed state. Humans have a
predominating PNS response. Over time, too much of an SNS response can link to decreased
HRV, psychopathology, and health risks such as diabetes, heart disease, and hypertension
(Appelhans & Luecken, 2006; Berntson et al., 1997).
Heart Rate Variability Measurement and Interpretation
Commonly, HRV is calculated by analyzing QRS complexes, which are Q, R, and S
waves reflected in a full cycle of a heartbeat. These are collected through an electrocardiogram
(Task Force, 1996) and considered the typical “spike” seen on an electrocardiogram machine.
All QRS stages occur between each R-R interval or the peak of the heartbeat seen on an
electrocardiogram machine (see Figure 2 for a visual description of a QRS complex). In recent
times, the measurement of HRV is through “wearable devices,” which provide a method for
detecting volumetric changes in blood circulation at the skin surface, or R-R intervals. (Georgiou
et al., 2018; Peake et al., 2018).
Figure 2
An Example of a QRS Complex via Electrocardiogram
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Note. From “Respiratory sinus arrhythmia: A transdiagnostic biomarker of emotion
dysregulation and psychopathology,” by T.P. Beauchaine, 2015, Current Opinion in
Psychology, 3, 43-47.
Frequency domain (FD) analyses are standard for reporting HRV and provide insight into
sympathetic and parasympathetic output (Achten & Jeukendrup, 2003; Beauchaine, 2015).
Within these analyses, HRV assumes well-defined rhythms connected to several regulatory
mechanisms that provide a high-frequency measurement (HF; 0.15-0.40 Hz) of HRV, or PNS
output. There is some inconsistency with findings for low-frequency (LF; 0.04-0.15 Hz) HRV.
Researchers have argued that LF-HRV measures variations of sympathetic reactions (Malliani et
al., 1991). However, others believe that LF-HRV measures influence of both sympathetic and
parasympathetic processes (Berntson et al., 1997; Kemp et al., 2012). Nonetheless, research has
supported higher LF-HRV and lower HF-HRV in those with anxiety compared to controls
(Chalmers et al., 2014).
It would be useful to explore if higher AS overall has a more robust prediction of HFHRV than LF-HRV outputs. Particularly given the ambiguity involved in what LF-HRV
measures. However, it is standard to report both HF-HRV and LF-HRV indices. This is due to
the assumption that each frequency measures opposing nervous system responses (Task Force,
1996). Researchers have also deemed both values as being perfectly linearly related. This perfect
correlation is because both parts should equal the whole of a nervous system response (both SNS
and PNS responding; Task Force, 1996). Therefore, analyzing both values, in theory, should not
provide further information. However, if LF-HRV does not solely measure SNS activity, the
reasoning for using HF- and LF-HRV becomes convoluted. This ambiguity could create
misunderstanding about how nervous system responses are connected to AS. Specifically, how
are both SNS and PNS represented in anxiety-inducing tasks. Since collecting both HF- and LF-
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HRV is standard, understanding what each frequency represents is vital for interpretation of
changes throughout HRV readings.
Influences on Heart Rate Variability
Age affects HRV. Those under the age of 30 have higher HF-HRV overall. However,
females have represented lower HF-HRV than males within this age range (Antelmi et al., 2004;
Umetani et al., 1998). In the previous study, age was controlled (Gourley, 2019) and rendered
no significance in the current sample. Notably, a meta-analysis by Koenig and Thayer (2016)
also found that females had lower HF-HRV overall. Additionally, the female heart had dominant
parasympathetic activity. The male heart had sympathetic dominance. The authors discussed
HRV data obtained from males and females could not be treated equally and that research needs
to emphasize or control for such differences when necessary.
Other potential influences on HRV are medications (e.g., Licht et al., 2009), pre-existing
health conditions (e.g., Schroeder et al., 2005; Stapelberg et al., 2012), socioeconomic status
(e.g., Hill et al., 2015; Jandackova et al., 2016), lifestyle (e.g., Maseli et al., 2017; Pope et al.,
1999), and physical activity (e.g., Maseli et al., 2017). These factors should be controlled when
possible. Still, one should use caution when generalizing HRV for everyone affected by AS.
Within the current study, these variables were not available. Considering the influence on AS,
further study of the connection between HRV and AS could contribute to knowledge of
physiological processes, particularly when known potential confounds are controlled.
Clinical Implications of Anxiety Sensitivity and Heart Rate Variability
Day-to-day variability in heartbeats is essential for many of the body’s physiological
functions (Beauchaine, 2015). Specifically, behavioral rigidity and dysregulation can be present,
representing many psychological disorders (e.g., Cohen et al., 1997; Kemp et al., 2012; Koenig
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et al., 2016; Thayer et al., 2009). Several of these disorders are linked to lower HRV overall, as
demonstrated by meta-analysis findings (Chalmers et al., 2014). Compromised HRV is found in
anxiety-related disorders specifically and those with significant worry regardless of anxiety
disorder diagnosis (Chalmers et al., 2016). However, it is important to recognize that most
research with HRV and anxiety has been with anxiety disorders, not AS. There is a need for
further connections and distinctions between AS and anxiety-related disorders in the context of
HRV.
Heart Rate Variability Used in Challenge Paradigms
Historically, HF-HRV has declined during exposure to stressful challenges that mimic the
three AS factors. Meta-analysis results reported significantly lower HF-HRV during periods of
distress and lower HF-HRV among diagnosed generalized anxiety disorder, obsessivecompulsive disorder, panic disorder, and social anxiety disorder populations compared to healthy
controls both at rest and during behavioral challenges (Castaldo et al., 2015; Blechert et al.,
2007).
Pittig and colleagues (2013) investigated anxiety disorders against controls when
engaging in anxiety-inducing tasks (e.g., hyperventilation). Those with a diagnosed anxiety
disorder exhibited lower HF-HRV compared to controls at baseline and during stressful tasks.
However, participants diagnosed with panic disorder showed the highest decrease during the
stressful tasks, specifically in the first 30 seconds of a hyperventilation challenge. Research was
limited by not controlling for influential factors such as medical conditions. Alvares and
colleagues (2013) also assessed HRV in those with social anxiety disorder compared to healthy
controls during a stressful task. Results revealed those with social anxiety disorder exhibited
significantly lower HRV compared to controls at baseline and during a stressful task. Given the
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results of HRV within behavioral challenges of anxiety disorders, it is likely HRV could be a
viable measure of challenge distress or anxiety within AS factors, particularly as most research
has focused on anxiety and anxiety-related disorders, not AS specifically.
Anxiety Sensitivity and Heart Rate Variability
There is minimal work on the relationship between HRV and AS. Although some novel
studies have explored the relationship, the findings are limited. For example, Schmidt and
colleagues (2001) examined AS and HRV after participants completed a CO2 challenge. Results
demonstrated that AS had predicted HRV reductions after the CO2 challenge. They also
collected other data such as increased heart rate and blood pressure reactivity, and these variables
were predictive of reported AS levels.
Moreover, research by Wearne and colleagues (2019) explored whether AS moderated
experiences of psychosocial stress with heart rate and skin conductance. Results indicated HFHRV decreased in response to the Trier Social Stress Test (TSST). Research examining HRV
and AS is limited. Investigating AS data and how it might impact HRV would be useful.
However, variables that influence HRV must be considered for reliable results. Variables to
consider would be gender, effects of specific challenges on HRV, or overall reported anxiety and
distress.
Previous Research on Heart Rate Variability, Anxiety Sensitivity, and Challenge
Paradigms
The current study is derived from a previous research study that explored the relationship
between HRV and AS (Gourley, 2019). They hypothesized that those with high AS would have
increased distress and decreased HF-HRV during anxiety-provoking challenges compared to
those with low to normative AS. Gourley (2019) had participants complete the ASI-3 online
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before coming in to complete the study. On average, participants completed it 23 days before
coming in for the in-person portion of the study. They also filled out the ASI-3 a second time
when they arrived for study procedures. They used the in-person ASI-3 scores for analyses.
Participants also completed the PROMIS® (Patient-Reported Outcomes Measurement
Information System), PROMIS ® Emotional Distress—Anxiety, and PROMIS® Emotional
Distress—Depression to assess baseline depression, anxiety, physical, mental, and social wellbeing.
Study procedures involved participants wearing a HRV monitor chest strap while
completing physical, cognitive, and social challenges at random. The physical challenge was a
brief guided hyperventilation exercise. Participants took full vital capacity breaths every 2
seconds for two minutes (Gourley, 2019). For the social challenge, participants completed the
Trier Social Stress Test (Wearne et al., 2019). Participants were instructed to create and present a
15-minute speech about “their most undesirable characteristic” and told the speech would be
recorded and evaluated by students and faculty. Participants had 10 minutes to prepare their
speech. After 10 minutes, the researcher told participants they did not have to perform the speech
(Gourley, 2019). Finally, the cognitive challenge was to complete a computerized version of the
Paced Auditory Serial Addition Task (PASAT). The PASAT-C (Lejuez et al., 2003) creates
psychological distress and physiological arousal (e.g., increased heart rate; Gourley, 2019).
Individuals must gradually increase their serial addition speed while experiencing an aversive
noise for all incorrectly answered items.
The previous researcher ran independent t-tests, repeated measures ANOVAs, and
MANOVAs to assess baseline HRV and HRV between each challenge presented. The HRV
results from Gourley’s (2019) study deviated from what was expected based on current literature
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and theories of anxiety and distress. The data demonstrated that those with high AS had
exhibited significant increases in subjectively reported distress during each challenge as
expected. However, HF-HRV was lower in normative AS participants than those with high AS.
At baseline, there were no significant differences in HF-HRV or LF-HRV between high and
normative groups. HF-HRV at each challenge compared to baseline had some nuanced
differences between each group. However, they were quite similar overall, indicating a weak or
absent relationship between AS and HRV. Notably, the most considerable difference between
groups was from baseline to the physical challenge. The high AS group experienced an increase
in HF-HRV relative to the normative group, which experienced a decrease in HF-HRV. This
relationship was the opposite of expectations with both groups and indicates parasympathetic
activation for the high AS group.
Furthermore, both groups experienced a decrease in HF-HRV from baseline to both
cognitive and social challenges. AS and HRV theory would expect a more considerable
reduction in the high AS group, but there were no significant differences overall. However, the
normative AS group had decreased LF-HRV overall compared to the high AS group, specifically
from baseline to social and cognitive challenges (Gourley, 2019). These results would suggest
more sympathetic activation in the low AS group compared to the high AS group although not
significantly different.
The subjective units of distress scale (SUDS), which measures in the moment distress,
was positively correlated as expected for the anxiety-provoking challenges. Lastly, ASI-3 scores
were significantly related to SUDS reporting for each challenge. In other words, those with high
AS scores reported higher SUDS ratings after completing associated challenges. Overall, this
study demonstrated inconsistent results. Because of the variability demonstrated, additional data
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analysis is warranted. Specifically, exploring what may have contributed to decreased HF-HRV
in those with high AS compared to normative or low AS individuals.
Conclusions
Minimal research has investigated how AS might be related to sympathetic activation.
The literature represents a relationship between compromised HRV and psychopathology in
general and within anxiety disorders specifically. Still, research becomes sparse when
introducing the potential relationship(s) between AS and HRV (e.g., Beauchaine, 2015),
indicating the need for further exploration. The current study explored different characteristics
that may have influences on the possible relationship between AS and HRV to potentially clarify
the conflicting prior findings in Gourley (2019). Exploring factors such as gender, different
levels of AS, and the administration of the ASI-3 could provide insight into how specific HRV
trends are an indicator of reported AS levels.
Study Aims and Hypotheses
Because of the variability found in HRV with anxiety and AS to a limited extent, it is
crucial to review nuanced findings between AS and HRV potentially impacting participants’ data
outcomes. This study aimed to explore connections between the ASI-3 and HRV to understand
what variables and factors influence AS and HRV within challenge paradigms. Therefore, this
study examined the following hypotheses:
1. High ASI-3 scores would predict a reduction in HF-HRV throughout each challenge
compared to baseline, normative ASI-3 scores, and LF-HRV.
2. In-person ASI-3 scores would be more predictive of challenge paradigm HF- and LFHRV consistent with the literature than online screening ASI-3 scores.
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3. Self-identified females would have lower HF-HRV and higher LF-HRV than selfidentified males at baseline and each challenge. Additionally, gender would moderate
the relationship between ASI-3 scores and HRV.
4. ASI-3 total scores in the lowest (< 11) and highest (> 34) third of the sample would
have the strongest linear relationship and correlation with HRV.
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Method
Measures
The current study utilized a subset of measures from the Gourley (2019) study to answer
the hypotheses.
Demographic Questionnaire
All participants in the previous study (Gourley, 2019) filled out a brief questionnaire on
their demographics, including socioeconomic status, employment, and education, to gather the
sample's general characteristics (see Table 1 for demographic information).
Anxiety Sensitivity Index-3 (ASI-3)
The ASI-3 is the most up-to-date self-report measure of AS and consists of 18 items.
Questions are rated on a 5-point Likert scale from 0 (very little) to 4 (very much). Questions relay
to how much individuals believe themselves to experience each statement (e.g., "It scares me
when I am unable to keep my mind on a task.", "It scares me when my heart beats rapidly.").
Scores range from 0 to 72 by adding each point value chosen for each question. The ASI-3
subscales, which are physical, cognitive, and social, are broken into six questions each (totaling
18) and possess strong internal consistency, even across cultures (Kemper et al., 2012; Petrocchi
et al., 2014; Taylor et al., 2007).
Physiological Measurement of Heart Rate Variability (HRV)
Participants wore a Polar® V800 (watch) with a Polar® H7 (chest strap) heart rate sensor
to record R-R intervals at baseline and during each challenge in the previous study (Gourley,
2019). Although HRV measurements were taken continuously, all R-R interval recordings
(baseline and during each behavioral challenge) were taken in five-minute increments. Fiveminute recordings are standard by the Task Force of the European Society of Cardiology (1996)
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to capture HRV data reliably. Values extracted were high-frequency (HF) HRV and lowfrequency (LF) HRV n.u.s utilized in the Gourley (2019) study. Research has identified ranges
for HF-HRV (0.15-0.40 Hz) and LF-HFV (0.04-0.15 Hz) indicating what ANS response (PNS or
SNS) is dominant at any given moment (Task Force, 1996).
Procedure
The current study reanalyzed data from a previously published dissertation at a
Midwestern university (Gourley, 2019). Complete study procedures are in the dissertation
(Gourley, 2019). Participants were recruited via voluntary research credit on SONA, an online
research participation portal for students at the university. Participants were also recruited via
fliers around campus and classroom visits conducted by the primary investigator. Participants
had to sign up for the study, consent to study procedures, and complete an online survey though
SONA. The survey was comprised of demographic variables, self-report clinical evaluations, and
the ASI-3 (see Appendix A-C; Gourley, 2019). Participants completed the ASI-3 again in-person
via a laboratory computer during the single experimental appointment. The primary
investigator’s protected survey software account stored ASI-3 data. Next, participants completed
a randomized series of challenges related to AS dimensions: a hyperventilation exercise, a
stressful cognitive task, and a stressful social task. HRV and distress via the subjective units of
distress scale (SUDS) were monitored before, throughout, and after each challenge.
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Results
Participants
The current study utilized data from Gourley (2019) to evaluate hypotheses. There were
185 students who completed the screening process and were eligible. Of them, 120 students (N =
120) completed the in-person portion of the study. Participants were predominantly female,
White and were on average 23.5 years old, with ages ranging from 18 to 63. The majority of
participants (91.7%) were taking an average of 10.1 credit hours (SD = 5.7; see Table 1 for
further demographic information).
Table 1
Demographics for AS Groups
Total Sample
(N = 120)
n%

High AS
(N = 60)
n%

Normative AS
(N = 60)
n%

78 (64.5)

46 (76.7)

32 (53.3)

1 (0.8)

1 (1.7)

White

84 (69.4)

40 (66.7)

44 (73.3)

Black/African American

19 (15.7)

9 (15.0)

10 (16.7)

Hispanic/Latino

5 (4.1)

2 (3.3)

3 (5.0)

Native American/ American Indian

5 (4.1)

3 (5.0)

2 (3.3)

Asian

11 (9.1)

6 (10.0)

5 (8.3)

Middle Eastern

5 (4.1)

4 (6.7)

1 (1.7)

Indian

1 (0.8)

1 (1.7)

Mixed race

1 (0.8)

1 (1.7)

3 (2.5)

2 (3.3)

1 (1.7)

We have enough to get by, but no more

22 (18.2)

9 (15.0)

13 (21.7)

We are solidly middle class

59 (48.8)

27 (45.0)

32 (53.3)

We have plenty of “extras”

32 (26.4)

19 (31.7)

13 (21.7)

4 (3.3)

3 (5.0)

1 (1.7)

111 (91.7)

60 (100.0)

51 (85.0)

Gender
Female
Non-Cisgender
Race

Socioeconomic Status
We barely have enough to get by

Don’t know/unsure/ prefer not to say
Student status
Enrolled in courses
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Descriptive Statistics
Initial analyses involved reviewing descriptive statistics including MS and SD of all
relevant study variables. For Anxiety Sensitivity Index-3 (ASI-3) total scores, averages were
similar between both administrations. There were no missing data for either online or in-person
administrations of the ASI-3. Of the 120 participants, 60 possessed normative levels (ASI-3
score ≤ 12), and 60 reported high scores (ASI-3 score ≥ 23) for the online screening
administration. For the in-person administration, a normative total score involved < 21, with the
high score value remaining unchanged. High AS had a mean score of 35.12 (SD = 10.87) online
and 35.48 (SD = 10.53) in-person. The normative AS group had an average score of 7.85 (SD =
3.19) online and 12.38 (SD = 7.34) in-person.
Next statistics determined the ASI-3 scores in both high and normative groups at both
administrations generally met assumptions of normality (see Table 2 for normality statistics).
Although the high ASI-3 group violated normality of the Shapiro-Wilks’s test, this test is
sensitive to small deviations in large data sets (Mishra et al., 2019). Therefore, skewness and
kurtosis better represent any violations and were within normal limits. Thus, data transformation
was unnecessary.
Hypothesis 4 involved analyzing data on participants with ASI-3 total scores in the
lowest and highest third of the sample only (N = 40 for each group). These two extreme groups
generally met assumptions of normality, similar to high and normative AS groups (Mishra et al.,
2019). Thus, no data transformations were conducted (see Table 2).
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Table 2
Descriptive Statistics for ASI-3 Scores in High, Highest, Normative, and Lowest AS Groups

Measure

M (SD)

Range

Skewness

Skew

Kurtosis

Z-score
ASI-3 online normative AS

Kurt

Shapiro-Wilk’s Test of

Z-score

Normality

7.85 (3.19)

1-12

-0.13

0.81

-1.32

1.63

p = .06

35.12 (10.87)

23-66

0.22

0.61

-0.04

1.33

p = .15

ASI-3 online lowest AS

6.62 (2.72)

1-10

-0.53

0.72

-0.98

1.4

p = .05

ASI-3 online highest AS

41.53 (9.52)

34-66

0.93

0.92

0.36

1.80

p = .06

ASI-3 in-person normative AS

12.38 (7.34)

1-21

0.07

0.63

-0.01

1.24

p = .08

ASI-3 in-person high AS

p < .001

ASI-3 online high AS

35.48 (10.53)

24-64

0.79

0.64

0.14

1.17

ASI-3 in-person lowest AS

6.08 (2.81)

1-10

-0.28

0.22

-1.27

1.76

p = .07

ASI-3 in-person highest AS

44.13 (7.21)

34-64

.91

1.01

.90

1.67

p < .001

Gourley (2019) examined heart rate variability (HRV) data to assure it followed protocol
and guidelines from the Task Force of the European Society of Cardiology (1996). Baseline
high-frequency (HF) and low-frequency (LF) HRV n.u.s were assessed as well, demonstrating
average HRV readings for the current sample. Ranges for both HF- and LF-HRV represented
possible HRV n.u.s ranges (see Tables 3-4 for HRV data with high and normative AS groups as
well as means between reported gender classifications). Given that all absolute values were
within normal range, skewness, kurtosis, and their associated z-values were not of concern with
the current data set (Mishra et al., 2019). Visual assessment of HRV readings indicated data to be
unimodal and asymmetrical in both high and normative groups. However, it is expected to have
positive skewness for HF-HRV and negative skewness for LF-HRV in an anxious population. It
is also not uncommon to find positive skewness for HF-HRV and negative skewness for LFHRV, generally. Most people have a dominant sympathetic response during the daytime and a
dominant parasympathetic response in the evening (Vaisakhi et al., 2017). HRV is also highly
individualized and complex, so establishing averages is difficult. Thus, the data did not require
transformation.
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Preliminary Analyses
T-tests were run between high and normative AS groups to see if HRV readings
significantly differed at baseline and each challenge. Results indicated no significant differences
between high and normative AS groups, which was consistent with Gourley (2019; see Table 3
for t-test results). Analyses of variances (ANOVAs) examined if there were significant
differences between means of key study variables in relation to reported gender. The sample
included one non-cisgender participant not included in analyses on gender. HRV analyses
examined HF- and LF-HRV n.u.s at baseline and each challenge. ANOVAs yielded significant
differences between gender groups for baseline, physical, cognitive, and social HF- and LF-HRV
(see Table 4 for ANOVA results). ANOVA results were only reported for HF-HRV as LF-HRV
results were identical. Females had higher HF-HRV and lower LF-HRV compared to males,
which was unexpected (see Table 4 for MS and SD). Additionally, an ANOVA assessed if ASI-3
total score means were significantly different between genders. There was a significant
difference, F(1, 118) = 13.85, p < .01, d = .79, with females (M = 27.01) having a higher average
ASI-3 total score than males (M = 17.61), as expected. Effect sizes for each ANOVA were
moderate (Cohen, 1977; see Tables 4 and 5 for an overview of ANOVA results).
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Table 3
HRV Indices at Baseline and During Behavioral Challenges for High and Normative AS Groups
High AS
Baseline

Normative AS

M (SD)

Range

M (SD)

t-test
Range

HF-HRV n.u.

(N = 56)

39.61 (19.22)

6.01-89.85

(N = 56)

34.69 (14.79)

6.49-67.27

LF-HRV n.u.

(N = 56)

60.28 (19.25)

9.95-93.96

(N = 56)

65.22 (14.80)

32.70-93.50

HF-HRV n.u.

(N = 56)

39.22 (19.81)

3.76-87.82

(N = 56)

31.14 (21.61)

10.32-91.60

LF-HRV n.u.

(N = 56)

60.74 (19.82)

12.16-96.23

(N = 56)

68.82 (21.62)

10.32-91.60

HF-HRV n.u.

(N = 57)

37.72 (19.42)

7.39-88.63

(N = 52)

35.12 (15.87)

4.59-71.67

LF-HRV n.u.

(N = 57)

62.20 (19.46)

11.26-92.53

(N = 52)

64.79 (15.86)

28.26-95.39

Cognitive

(N = 55)

HF-HRV n.u.

(N = 54)

36.55 (19.95)

7.14-89.08

(N = 56)

38.25 (17.09)

5.09-77.45

LF-HRV n.u.

(N = 54)

63.26 (20.04)

10.71-92.85

(N = 56)

61.65 (17.11)

22.50-94.89

t(108) = 0.71, p = 0.48

Physical
t(110) = 1.88, p = 0.06

Social
t(107) = 0.22, p = 0.83

t(105) = 0.19, p = 0.85

Notes. N = 120. HF- and LF-HRV n.u. refer to high-frequency and low-frequency heart rate variability
normalized units.

Table 4

HRV Indices at Baseline and During Behavioral Challenges for Reported Gender
Males
Baseline

(N = 39)

HF-HRV n.u.
LF-HRV n.u.
Physical

Females

M (SD)

Range

33.34 (17.52)
66.58 (17.55)

6.01-71.13
28.86-93.96

(N = 39)

(N = 73)

ANOVA

M (SD)

Range

40.53 (17.42)
59.36 (17.43)

12.23-89.85
9.95-87.77

F(1, 110) = 4.87, p = .03*, d = .42

F(1, 110) = 12.92, p < .001**, d = .78

(N = 73)

HF-HRV n.u.

28.39 (18.03)

3.76-83.47

40.55 (19.97)

8.52-89.63

LF-HRV n.u.

71.55 (18.06)

16.52-96.23

59.4 (19.98)

10.32-91.48

HF-HRV n.u.

31.46 (18.42)

7.39-88.63

41.69 (16.87)

4.59-71.67

LF-HRV n.u.

68.42 (18.46)

11.26-92.53

58.14 (16.86)

28.26-95.39

Social

Cognitive

(N = 39)

(N = 70)

(N = 40)

F(1, 109) = 10.20, p < .01**, d = .70

(N = 70)

HF-HRV n.u.

30.82 (15.45)

5.09-65.36

42.49 (18.84)

7.70-89.08

LF-HRV n.u.

69.10 (15.46)

34.37-94.89

57.41 (18.90)

10.71-92.26

F(1, 108) = 8.32, p < .01**, d = .62

Notes. N = 120. HF- and LF-HRV n.u. refer to high-frequency and low-frequency heart rate
variability normalized units. * = p < .05. ** = p < .01.
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Table 5
One-Way ANOVA for ASI-3 Scores with Gender as the Predictor
SS

Predictor

df

MS

Gender

2702.42

1

2702.42

Error

23029.04

118

195.16

F
13.85

p

2
partial η

.000**

.11

Notes. SS = Sum of Squares, dF = Degrees of Freedom, MS = Mean of Squares. ** = p < .01.

Paired t-tests assessed if HF- or LF-HRV were significantly different from baseline at
each challenge. T-tests revealed no significant differences, suggesting HRV was not significantly
affected by challenges (see Table 6 for t-test results).
General correlations examined relationships between both administrations of the ASI-3
and HF- and LF-HRV readings at baseline and each challenge. For online and in-person ASI-3
scores, correlations were weak (see Tables 7 and 8 for correlation tables). Finally, correlations
were non-significant between ASI-3 scores and HRV, suggesting a weak or absent relationship
between these variables.
Table 6
Paired T-Tests for Baseline HF-HRV to Associated Behavioral Challenge HF-HRV Readings
M (SD)
M Baseline HF-HRV

39.61 (19.22)

M Social HF-HRV

37.72 (19.42)

M Physical HF-HRV

39.22 (19.81)

M Cognitive HF-HRV

36.55 (19.95)

t-test

Baseline to Social HF-HRV

t(103) = 0.33, p = 0.74

Baseline to Physical HF-HRV

t(106) = 0.33, p = 0.71

Baseline to Cognitive HF-HRV

t(104) = 0.24, p = 0.81

Notes. N = 120. HF-HRV refers to high-frequency heart rate variability.
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Table 7
Correlations for Online ASI-3 Scores and HRV
Variable

1

2

3

4

5

6

7

8

1. Online ASI-3 scores
2. Baseline HF-HRV n.u.

-.00
[-.19, .19]

3. Social HF-HRV n.u.

-.08
[-.26, .11]

.68**
[.57, .77]

4. Physical HF-HRV n.u.

.12
[-.06, .30]

.32**
[.14, .48]

5. Cognitive HF-HRV
n.u.

-.09
[-.27, .10]

.65**
[.53, .75]

.38**
[.20, .53]
.67**

.38**

[.54, .76]

[.21, .53]

6. Baseline LF-HRV n.u.

.00
[-.19, .19]

-1.00**
[-1.00, -1.00]

-.69**
[-.78, -.57]

-.33**
[-.49, -.14]

-.65**
[-.75, -.53]

7. Social LF-HRV n.u.

.08
[-.11, .26]

-.68**
[-.77, -.57]

-1.00**
[-1.00, -1.00]

-.38**
[-.53, -.20]

-.67**
[-.76, -.54]

.68**
[.57, .77]

8. Physical LF-HRV n.u.

-.12
[-.30, .06]

-.32**
[-.48, -.14]

-.38**
[-.53, -.20]

-1.00**
[-1.00, -1.00]

-.38**
[-.53, -.21]

.33**
[.14, .49]

9. Cognitive LF-HRV
n.u.

.08
[-.11, .27]

-.65**
[-.75, -.52]

-.66**
[-.76, -.54]

-.38**
[-.53, -.21]

-1.00**
[-1.00, -1.00]

.65**
[.52, .75]

.38**
[.20, .53]
.67**
[.54, .76]

Notes. Values in square brackets indicate the 95% confidence interval for each correlation. ** indicates p < .01.

.38**
[.21, .53]
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Table 8
Correlations for In-Person ASI-3 Scores and HRV
Variable

1

2

3

4

5

6

7

8

1. In-person ASI-3
scores
2. Baseline HF-HRV n.u.

.09
[-.10, .27]

3. Social HF-HRV n.u.

-.01
[-.19, .18]

.68**
[.57, .77]

4. Physical HF-HRV n.u.

.13
[-.06, .31]

.32**
[.14, .48]

5. Cognitive HF-HRV
n.u.

-.06
[-.24, .13]

.65**
[.53, .75]

.38**
[.20, .53]
.67**

.38**

[.54, .76]

[.21, .53]

6. Baseline LF-HRV n.u.

-.09
[-.27, .10]

-1.00**
[-1.00, -1.00]

-.69**
[-.78, -.57]

-.33**
[-.49, -.14]

-.65**
[-.75, -.53]

7. Social LF-HRV n.u.

.01
[-.18, .19]

-.68**
[-.77, -.57]

-1.00**
[-1.00, -1.00]

-.38**
[-.53, -.20]

-.67**
[-.76, -.54]

.68**
[.57, .77]

8. Physical LF-HRV n.u.

-.13
[-.31, .06]

-.32**
[-.48, -.14]

-.38**
[-.53, -.20]

-1.00**
[-1.00, -1.00]

-.38**
[-.53, -.21]

.33**
[.14, .49]

9. Cognitive LF-HRV
n.u.

.05
[-.13, .24]

-.65**
[-.75, -.52]

-.66**
[-.76, -.54]

-.38**
[-.53, -.21]

-1.00**
[-1.00, -1.00]

.65**
[.52, .75]

.38**
[.20, .53]
.67**
[.54, .76]

Notes. Values in square brackets indicate the 95% confidence interval for each correlation. ** indicates p < .01.

.38**
[.21, .53]
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Hypothesis 1: Are HF- and LF-HRV Perfectly Correlated?
Correlations assessed relationships between ASI-3 scores and HRV to address
Hypothesis 1. It was unknown before data analyses if HF- and LF-HRV would be the inverse of
each other as partially expected in the conflicting literature (Task Force, 1996). It was also
unknown if there would be discrepancies in relationships between HF- and LF-HRV correlation
coefficients and ASI-3 scores (e.g., Berntson et al., 1997). Within the current sample, perfectly
correlated coefficients occurred between HF- and LF-HRV to their comparative baseline and all
challenge counterparts (see Tables 7 and 8). Therefore, both HF- and LF-HRV would have
similar predictive values compared to ASI-3 scores and remaining analyses involve only HFHRV results.
Hypothesis 2: Did Online and In-Person ASI-3 Scores Differ in Relational Strength to HRV
Readings?
For Hypothesis 2, correlations assessed general trends in data between ASI-3
administrations across HF-HRV in high and normative AS groups. Fisher’s r-to-z
transformations examined scores between ASI-3 administrations and HF-HRV correlations.
Along with the relationship between these variables, this analysis could determine which version
of ASI-3 administration is most robust in this sample. The Lee and Preacher (2013) calculator
computed these analyses. Fisher’s r-to-z transformations revealed no significant differences for
those with high AS (see Table 9 for specific p-values). However, there was a significant
difference in baseline HF-HRV (z = -1.70, p = .04) for the normative AS group. Specifically, inperson ASI-3 scores had a stronger relationship with HF-HRV. Findings suggest a positive
correlation with normative AS group and HF-HRV, as expected. There was no other significant
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difference between administrations with the normative AS group (see Table 10 for specific z-and
p-values).
Although there were no significant differences other than baseline HRV scores in the
strength of correlations, remaining analyses utilized in-person scores. Gourley (2019) also
utilized these scores, and they reflect the current AS level when participants completed the
challenges. Additionally, given the prior research indicating the second administration is most
reflective of AS (Marsic et al., 2011) also justifies using the second administration in-person
scores.
Table 9
Fisher’s r-to-z Transformations Between Administrations of ASI-3 in Relation to HRV for High
AS Individuals
Variable

r

Online ASI-3 to baseline HF-HRV for high AS group

-.12

In-Person ASI-3 to baseline HF-HRV for high AS group

-.02

Fisher’s r-to-z transformation
Online ASI-3 to social HF-HRV for high AS group

-.20

In-person ASI-3 to social HF-HRV for high AS group

-.14

Fisher’s r-to-z transformation
Online ASI-3 to physical HF-HRV for high AS group

.02

In-person ASI-3 to physical HF-HRV for high AS group

.04

Fisher’s r-to-z transformation
Online ASI-3 to cognitive HF-HRV for high AS group

-.05

In-person ASI-3 to cognitive HF-HRV for high AS group

.06

Fisher’s r-to-z transformation

Fisher’s r-to-z value

p

-0.77

p = .22

-0.47

p = .32

-0.15

p = .44

-0.84

p = .20

Notes. r was used to represent Pearson correlation coefficients. Fisher’s r-to-z value represents z
values after running a Fisher r-to-z transformation with the corresponding set of coefficients
being compared. LF-HRV was not reported as results were identical to HF-HRV.
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Table 10
Fisher’s r-to-z Transformations Between Administrations of ASI-3 in Relation to HRV for
Normative AS Individuals
Variable

r

Online ASI-3 to baseline HF-HRV for normative AS group

-.07

In-Person ASI-3 to baseline HF-HRV for normative AS group

.15

Fisher’s r-to-z transformation
Online ASI-3 to social HF-HRV for normative AS group

.15

In-person ASI-3 to social HF-HRV for normative AS group

.27

Fisher’s r-to-z transformation
Online ASI-3 to physical HF-HRV for normative AS group

.07

In-person ASI-3 to physical HF-HRV for normative AS group

.11

Fisher’s r-to-z transformation
Online ASI-3 to cognitive HF-HRV for normative AS group

.09

In-person ASI-3 to cognitive HF-HRV for normative AS group

.06

Fisher’s r-to-z transformation

Fisher’s r-to-z value

p

-1.70

p = .04*

-0.95

p = .17

-0.31

p = .38

0.23

p = .41

Notes. r was used to represent Pearson correlation coefficients. Fisher’s r-to-z value represents z
values after running a Fisher r-to-z transformation with the corresponding set of coefficients
being compared. LF-HRV was not reported as results were identical to HF-HRV. * = p < .05

Hypothesis 3: Does Gender Moderate ASI-3 Scores and Heart Rate Variability?
Given the significant differences based on gender covered in preliminary analyses, a
moderation test examined if gender impacted the relationships between in-person ASI-3 scores
and HRV. Moderation results were insignificant for baseline, F(3, 108) = 0.57 p = .64; physical,
F(3, 108) = 0.14 p = .94; cognitive, F(3, 106) = 0.08 p = .97; and social HRV readings, F(3, 105)
= 0.28 p = .84. Gender did not moderate an effect between ASI-3 scores and HRV across
challenges (see Tables 11-14 for moderation results).
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Table 11
Moderation Results with Baseline HF-HRV, ASI-3 Scores, and Gender
Predictor
(Intercept)
ASI-3 scores (mean-centered)
Gender
ASI-3 scores*Gender

b
38.16**
-0.35
-1.72
1.17

b
95% CI
[LL, UL]
[34.83, 41.50]
[-3.71, 3.01]
[-5.18, 1.75]
[-2.30, 4.64]

sr2
.00
.01
.00

sr2
95% CI
[LL, UL]

Fit

[-.01, .01]
[-.03, .04]
[-.02, .03]
R2 = .016
95% CI[.00,.06]

Notes. A significant b-weight indicates the semi-partial correlation is also significant. b represents unstandardized regression
weights. sr2 represents the semi-partial correlation squared. LL and UL indicate the lower and upper limits of a confidence
interval, respectively. ** = p < .01.
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Table 12
Moderation Results with Physical HF-HRV, ASI-3 Scores, and Gender
Predictor
(Intercept)
ASI-3 scores (mean-centered)
Gender
ASI-3 scores*Gender

b
36.66**
-1.07
-0.71
0.36

b
95% CI
[LL, UL]
[32.78, 40.53]
[-5.08, 2.94]
[-4.82, 3.39]
[-3.80, 4.53]

sr2
.00
.00
.00

sr2
95% CI
[LL, UL]

Fit

[-.02, .02]
[-.01, .01]
[-.01, .01]
R2 = .004
95% CI[.00,.02]

Notes. A significant b-weight indicates the semi-partial correlation is also significant. b represents unstandardized
regression weights. sr2 represents the semi-partial correlation squared. LL and UL indicate the lower and upper limits of a
confidence interval, respectively. ** = p < .01.
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Table 13
Moderation Results with Cognitive HF-HRV, ASI-3 Scores, and Gender
Predictor
(Intercept)
ASI-3 scores (mean-centered)
Gender
ASI-3 scores*Gender

b
37.98**
-0.07
-0.45
0.73

b
95% CI
[LL, UL]
[34.49, 41.47]
[-3.66, 3.51]
[-4.17, 3.28]
[-3.03, 4.49]

sr2
.00
.00
.00

sr2
95% CI
[LL, UL]

Fit

[-.00, .00]
[-.01, .01]
[-.01, .02]
R2 = .002
95% CI[.00,.00]

Notes. A significant b-weight indicates the semi-partial correlation is also significant. b represents unstandardized
regression weights. sr2 represents the semi-partial correlation squared. LL and UL indicate the lower and upper limits of a
confidence interval, respectively. ** = p < .01.
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Table 14
Moderation Results with Social HF-HRV, ASI-3 Scores, and Gender
Predictor
(Intercept)
ASI-3 scores (mean-centered)
Gender
ASI-3 scores*Gender

b
38.21**
0.38
-0.20
1.56

b
95% CI
[LL, UL]
[34.75, 41.66]
[-3.31, 4.08]
[-3.84, 3.44]
[-2.13, 5.24]

sr2
.00
.00
.01

sr2
95% CI
[LL, UL]

Fit

[-.01, .01]
[-.00, .00]
[-.02, .04]
R2 = .008
95% CI[.00,.04]

Notes. A significant b-weight indicates the semi-partial correlation is also significant. b represents unstandardized
regression weights. sr2 represents the semi-partial correlation squared. LL and UL indicate the lower and upper limits of a
confidence interval, respectively. ** = p < .01.
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Hypothesis 4: Highest and Lowest Thirds of ASI-3 Scores More Predictive of HRV?
Correlations and Fisher’s r-to-z transformations assessed the relationship between inperson ASI-3 total scores in the highest and lowest thirds of the sample and HRV readings (N =
40 for each group). Figure 3 depicts the average HF-HRV data across AS level and conditions.
Figure 3

HF-HRV n.u.

Average HF-HRV at Baseline and Each Challenge for Highest and Lowest AS Groups

45
43
41
39
37
35
33
31
29
27
25
Baseline

Physical
Lowest AS

Cognitive

Social

Highest AS

Note. N = 40 for each group. There were no significant differences between groups.
Following computing correlations, Fisher’s r-to-z transformations utilizing the r-to-z
calculator created by Lee and Preacher (2013) determined differences across AS levels. Results
indicated a significant difference between lowest and highest AS scores for social HF-HRV (p =
.01). Correlations revealed those with the lowest AS scores positively correlated with social HFHRV (r = .24) as expected. Those in the highest AS group had a negative correlation with social
HF-HRV (r = -.07). All other correlations were non-significant (p > .05). These findings suggest
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differences in correlations with HRV readings were not contingent upon higher or lower levels of
reported AS during physical or cognitive challenges (see Table 15).
Table 15
Fisher’s r-to-z Transformations Between Lowest and Highest ASI-3 Scores Compared to HRV
Readings
Variable

r

Fisher’s r-

p

to-z value
ASI-3 to baseline HF-HRV for lowest AS group

.02

ASI-3 to baseline HF-HRV for highest AS group

.06

Fisher’s r-to-z transformation
ASI-3 to social HF-HRV for lowest AS group

.24

ASI-3 to social HF-HRV for highest AS group

-.07

Fisher’s r-to-z transformation
ASI-3 to physical HF-HRV for lowest AS group

.16

ASI-3 to physical HF-HRV for highest AS group

.18

Fisher’s r-to-z transformation
ASI-3 to cognitive HF-HRV for lowest AS group

-.05

ASI-3 to cognitive HF-HRV for highest AS group

.05

Fisher’s r-to-z transformation

-0.30

p = .38

2.42

p = .01**

-0.16

p = .44

-0.77

p = .22

Notes. N = 40 for each group. r was used to represent Pearson correlation coefficients. Fisher’s rto-z value represents z values after running a Fisher r-to-z transformation with the corresponding
set of coefficients being compared. LF-HRV was not reported as results were identical to HFHRV. ** = p ≤ .01.
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Discussion
The current study examined relationships between anxiety sensitivity (AS) and heart rate
variability (HRV) through completing challenges expected to provoke anxiety. Outcomes from a
previous study (Gourley, 2019) found results inconsistent with the current literature. Specifically,
theoretically high-frequency (HF) HRV should decrease in higher AS levels (Chalmers et al.,
2014). Findings resulted in weak or absent relationships between AS and HRV. Gourley (2019)
did not examine the predictive value between HF- and low-frequency (LF) HRV, gender, and AS
levels based on established cutoffs via ASI-3 scores. This study attempted to further explain the
unexpected results.
Hypothesis 1: Are HF- and LF-HRV Perfectly Correlated?
The first hypothesis explored if HF- and LF-HRV n.u.s were computationally identical as
identified by Denver (2007). The literature has demonstrated ambiguity around what LF-HRV
measures (Bernston et al., 1997; Malliani et al., 1991) related to the ANS.
The current hypothesis was supported. HF- and LF-HRV were perfectly linearly related
to one another. Findings suggest HF- and LF-HRV are the inverse of one another and represent
their expected nervous system responses. This result further supports research suggesting HFHRV represents the PNS and LF-HRV represents SNS (Chalmers et al., 2014; Malliani et al.,
1991). Additionally, these results align with meta-analytic findings measuring outcomes of HFand LF-HRV in anxiety disorders. However, extraneous factors can affect HRV outcomes at any
given moment. Influential factors make its use less reliable unless these are controlled. If they
are not, results may produce ambiguous findings, even if relationships are present.
Research has investigated problematic outcomes of using LF-HRV as a measure (e.g.,
Acharya et al., 2006; Goldstein et al., 2011). These problems primarily stem from the nervous
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system's influence on LF-HRV readings, especially compared to HF-HRV. Future research
should explore the utility of using both HF- and LF-HRV n.u.s when reporting HRV.
Exploration could indicate if HF- and LF-HRV are computationally identical and, if they are,
why both should be reported.
Hypothesis 2: Did Online and In-Person ASI-3 Scores Differ in Relational Strength to HRV
Readings?
Research by Marsic and colleagues (2011) and Maltby and colleagues (2005) informed
this hypothesis. They indicated a decrease in ASI and ASI-3 scores from the initial
administration of the questionnaire to the second administration and stable scores beyond two
administrations. Because participants filled out the ASI-3 for online screening and again when
they came to complete study procedures, expected outcomes would be a difference in scores
between administrations. Specifically, in-person scores would have a stronger relationship with
HF-HRV than the online ASI-3 scores. This difference stems from changes in completing the
ASI-3 a second time and in a controlled environment, directly before completing challenges.
This study found minimal support for this hypothesis. Correlations, means, and Fisher’s
r-to-z transformations revealed scores between in-person and online administrations were quite
similar. Additionally, the correlations between both administrations and HRV were not
significantly different. However, there was a significant difference in baseline HF-HRV readings
for the normative group between both administrations. In-person scores had a stronger positive
relationship with HF-HRV compared to the online administration. These results suggest that the
higher the ASI-3 score in the normative range, the higher the HF-HRV reading or PNS response.
However, correlations were still weak, and those in the normative group did not meet clinical
thresholds for elevated AS making the results less meaningful.
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According to current research (Chalmers et al., 2014; Pittig et al., 2013), it would be
expected that higher AS is associated with lower PNS activity at baseline and during challenges.
However, this was not found for those with high AS, lending to a weak or absent relationship.
No other differences in correlations were significant, so there were minimal differences,
generally. Thus, most correlations suggested there was not enough evidence to reject the null
hypothesis. Baseline readings become necessary for HRV as they set a basis for comparison. The
current sample demonstrated baseline readings trending away from expectations, lending to the
assumption that this trend would likely continue with other analyses.
It is unclear what could account for this trend in data for the current sample. However,
individuals in the normative AS group were considered to have “normal” (or non-clinical) AS
levels. Other variables may have influenced correlations in the current sample. Variables not
considered, such as antidepressant use, could influence HRV. However, antidepressants would
typically compromise HRV, lending to expected relationships between variables, unlike the
results in this study. Other influential variables that affect HRV not accounted for are other
medication use, medical conditions, physical fitness, and socioeconomic status (e.g., Hill et al.,
2015; Jandackova et al., 2016; Licht et al., 2009; Maseli et al., 2017; Schroeder et al., 2005;
Stapelberg et al., 2012). Future research should accommodate for known variables that influence
HRV to review a more direct relationship between AS and HRV, especially considering the
unexpected relationships in less controlled studies.
Evidence presented in current analyses with ASI-3 scores demonstrated stability across
time and medium of administration in contrast to other researchers. There was also high internal
consistency and test-retest reliability presented with both administrations of the ASI-3. Findings
suggest integrity between these types of administration for the current sample. Further research
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should be done concerning the efficacy of the ASI-3 as reliability and internal consistency may
be higher than previously suggested by Taylor and colleagues (2007). Overall, unknown
variables may have influenced HRV ratings in this study. However, there is still further support
for the ASI-3 in measuring AS across time.
Hypothesis 3: Does Gender Moderate ASI-3 Scores and Heart Rate Variability?
The third hypothesis relates to influences of gender on HRV (Koenig & Thayer, 2016).
This hypothesis expected gender to moderate the relationship between ASI-3 scores and HRV,
with females having lower HF-HRV compared to males. This finding would suggest less
variability overall. Taylor and colleagues (2007) suggested that females have higher ASI-3
scores than males, which implies higher ASI-3 scores indicate lower HF-HRV.
Gender did not moderate the relationship between ASI-3 scores and HRV despite the
significant differences between groups. The unexpected direction of mean differences included
self-identified males demonstrating lower HF-HRV than females at baseline and each challenge.
ASI-3 scores had significant mean differences, with females having higher ASI-3 scores than
males, as expected (e.g., Christiansen et al., 2015; McLean et al., 2011; Osman et al., 2010).
Given these differences the moderation tests were insignificant.
It is unclear why gender would not moderate ASI-3 scores and HRV. Potentially, the
ASI-3 scores and HRV contradicted one another eliminating the option for ASI-3 scores to
predict HRV by gender. Current outcomes align with the Simpson’s Paradox, which is when a
trend appears in different data groups, but disappears/reverses when combining groups.
Simpson’s paradox is not uncommon in data analyses. It highlights the importance of assessing
multiple variables when evaluating relationships. Lastly, it is important to note that the ratio of
males to females in the normative group was roughly equal. However, approximately 75% of the
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high AS group consisted of females. There could be a lack of clarity from the current dataset
from uneven ratios of both gender groups, particularly for the high AS group. Future research
should consider the implications of assessing gender as a moderator within the relationship
between AS and HRV.
Previously mentioned research by Koenig and Thayer (2016) indicated females had a
dominant PNS response, while males were the opposite with SNS reactions. If this were the case
with the current sample, HRV readings would align with the literature. Future research would
benefit from examining if AS levels within a specific gender group correlate with HRV readings
(e.g., lower HF-HRV for those with higher ASI-3 scores). Based on ANOVA results, gender,
ASI-3 scores, and HRV appear to have relationships with one another. What is unclear is how
ASI-3 scores would not influence HRV when gender predicted them both. Overall, gender could
have a different relationship than expected with AS and HRV, which should be further evaluated.
The current sample had primarily enrolled undergraduate students around 23.5 years of
age. Reported anxiety is exceptionally high within the college student population (e.g., Hunt &
Eisenberg, 2010). Additionally, many published studies utilize clinical populations (or elevated
anxiety compared to the general population). HRV may only be a useful biomarker within
clinical populations, not solely elevated AS. Furthermore, HRV did not seem influenced by
experiencing AS in the moment with challenges expected to provoke anxiety. This is particularly
surprising given subjective distress predicted ASI-3 scores during baseline and across challenges
in previous findings (Gourley, 2019). Overall, further investigation may indicate a lack of utility
in measuring HRV and AS outside of clinical populations.
According to Taylor and colleagues (2007), most studies completed thus far using ASI-3
scores had average ages older than the current study sample. HRV decreases with age (e.g.,
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Antelmi et al., 2004; Umetani et al., 1998). Given the current young sample, this may introduce
another potential confounding variable. Age was significantly skewed in both high and
normative groups in the present sample, without any significant difference in reported age based
on ASI-3 scores. Therefore, age was not explored because it was not variable and is known only
to affect HRV across the lifespan. Future research would benefit from a diverse sample that
includes mixed age ranges to examine how age might moderate reported AS and HRV. If HRV
is not affected by AS in younger populations, the utility of using HRV as a biomarker for AS
becomes less probable, even when controlling for gender. Overall, gender influences HRV, but
further research is warranted as to how gender affects HRV, ASI-3 scores, and other
confounding variables that can co-occur with gender differences.
Hypothesis 4: Highest and Lowest Thirds of ASI-3 Scores More Predictive of HRV?
AS and HRV literature has controversial findings regarding if AS predicts a reduction in
HRV (e.g., Blom et al., 2012; Kemp et al., 2012). The current study wanted to explore if higher
and lower scores reflected by the ASI-3 demonstrated stronger correlations with HRV readings.
If AS impacted HRV, this would be most obvious for more extreme scores.
Most Fisher r-to-z transformations revealed no significant differences for those with the
highest or lowest reported ASI-3 scores. However, social HF-HRV had significant differences
between groups lending partial support for Hypothesis 4. Specifically, those with lower AS had a
dominant PNS response, while those with high AS exhibited the opposite SNS response. HFHRV occurred as expected based on previous research (e.g., Gorman & Sloan, 2000), but for the
social challenge only. It should be noted that the social subscale had the highest mean of any
subscale on the ASI-3, which could indicate the social subscale was the dominant anxietyinducing dimension within the current sample.
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With only the social challenge demonstrating a stronger correlation between ASI-3 scores
and HRV, there is the possibility the physical and cognitive challenges were intense for all
participants. For example, hyperventilation taps into AS if there is a fear of innocuous physical
sensations when physically aroused from a stressor. However, some discomfort has been
reported during hyperventilation challenges, even in non-clinical populations. This discomfort is
not associated with anxiety or AS specifically (e.g., Feldner et al., 2003; Kelly et al., 2006).
Physical activity or alterations to physiological responses such as hyperventilation can also
compromise HRV in the moment. It would be difficult to differentiate whether or not changes in
HRV stem from AS or altering one’s rate of breathing (Beauchaine, 2015).
For the cognitive challenge, the PASAT is stressful for clinical and non-clinical
populations (Lejuez et al., 2003). Furthermore, the test can produce a startle response, which
may impact HRV directly. In Figure 3, there was an increase in HF-HRV for those with the
lowest scores and the opposite for those with the highest ASI-3 scores. These findings suggest
that the lowest AS group had PNS activation while experiencing the cognitive stressor with an
uncharacteristic relaxation-based response. No research to date has reported an increase in HFHRV during an anxiety-provoking challenge. Future studies should examine how each
behavioral challenge affects changes in HRV from baseline outside of AS levels.
However, even with these issues in mind, the social dimension had the highest mean
scores amongst all reported levels of AS. Higher scores potentially indicate the social dimension
universally impacted this sample. Overall, there is evidence supporting the Trier Social Stress
Test’s effectiveness when examining HRV and AS, which requires further investigation.
A limitation of the current sample is the lack of participants classified as “low AS.” Originally,
Gourley (2019) intended to have three AS groups: high, normative, and low. However, due to
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difficulty recruiting participates with low AS, the study included only high and normative AS
groups. Obtaining evenly distributed individuals with low and high AS may lead to significant
differences that were not present in the lowest and highest one third of participant ASI-3 scores
for this study. Finally, exploring relationships between high and low subscale scores should be
considered to provide strength in each AS dimension’s relationships with HRV.
Assessing psychological diagnoses within the sample may allow evaluation of other
factors that can influence PNS and SNS. For example, Dishman and colleagues (2000) found that
reduced HF-HRV and perceived distress were independent of cardiovascular health and fitness.
However, they also found unrelated trait-anxiety and HRV readings. The ASI-3 measures traitlike dimensions of anxiety, again lending questions concerning the use of HRV as a reliable
outcome of AS (Watkins et al., 1998). Still, the current study shows promise for the social
dimension, which is far less studied in relation to AS. Further replication of these results may
demonstrate the utility of the social challenge specifically.
Limitations
In addition to the limitations already discussed, other study factors serve as limitations
and considerations for future work. One limitation involves using a college student population.
As previously mentioned, university students are known to have high anxiety and depression
rates (e.g., Hunt & Eisenberg, 2010). The university in question is also a commuter college,
making the student body’s circumstances unique compared to many mid-sized universities.
Although not examined in the current study, Gourley (2019) found that 24% of the study sample
met PROMIS® Emotional Distress cutoff criteria for depression and 30% for anxiety. This is
substantially higher than the prevalence of anxiety (18.1%) and depression (6.7%) in the U.S.
(e.g., Kessler et al., 2005). In this sample, those with high AS more than likely had significant
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symptom endorsement. However, no conclusions can be made without formal assessment for
psychopathology. Future research should engage in a comprehensive assessment of
psychopathology, especially if HRV is consistently compromised in clinical populations.
In addition to being a college student population, age was not variable within the current
sample. The present study’s results are not generalizable to all age ranges and is limited in terms
of how HRV is compromised in older individuals (Antelmi et al., 2004; Umetani et al., 1998).
Thus, one suggestion involves adequate representation or longitudinal research of HRV and AS
across the lifespan.
As previously mentioned, this study did not control for several factors that could
influence HRV as confounding variables such as antidepressant use. Similar to what was
reported by Gourley (2019), a large percentage of individuals with reported anxiety or depressive
disorders typically take at least one antidepressant (Eisenberg & Chung, 2012). Additionally,
about a quarter of the sample met the criteria on the PROMIS® Emotional Distress scale. It
seems highly likely that a portion of the participants were currently taking an antidepressant.
Future studies could control for medication use or evaluate its impact on HRV.
Each challenge completed could have different effects on AS or HRV comparatively,
demonstrating a possible confounding variable. Although strong research suggests the behavioral
challenges used reflect the AS factors (e.g., Castaldo et al., 2015; Hughes & Stoney, 2000),
others report differential HRV responses (Hu et al., 2016). These findings suggest additional
research is needed on HRV across AS factor challenges. Furthermore, carryover effects from
previous challenges, particularly physical, may impact results. HRV influences can last up to 1-3
days depending on a strong enough response to a stimulus. These influences are especially true if
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the stimulus has to do with physical altercations such as respiration and physical activity
(Dishman et al., 2000; Pittig et al., 2013).
Conclusions and Future Directions
With variable results in the literature, the current study again supports the notion that
HRV is complex. Additional research can explore factors that potentially influence HRV.
However, in the current study and Gourley (2019), the social challenge was particularly
promising. Additionally, HF-HRV and LF-HRV displayed a linear relationship. Finally, gender
and more extreme ASI-3 scores showed some impact on the relationship with HRV.
There are several opportunities available to examine HRV and AS. Specifically, to
increase reliable findings, in-depth assessments should cover a participant’s history of medical
conditions, medication use, lifestyle, physical fitness, psychopathology, age, gender, and
socioeconomic status. Additionally, effects of behavioral challenges could differentially affect
HRV. Future research should examine the effects of behavioral challenges on HRV. Further
study could determine the best challenges to reflect AS dimensions. Also, future studies could
control for carryover effects and consider how to counterbalance challenges without negative
impact on HRV. Mediation and moderation tests could help to understand what variables
influence HRV. Specifically, age, gender, and physical activity factors likely impact HRV and
AS. Increasing sample characteristics (e.g., diversity in age, gender, race, ethnicity,
socioeconomic status, and clinical/non-clinical populations) could improve generalizability of
findings. Finally, given the controversial nature of the literature, replicating study findings is
particularly important.
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Appendix A: Screening Questionnaire
1. How old are you?
2. Are you
a. Male
b. Female
c. Non-cisgender
Do you smoke, either occasionally or
daily?___________________________________________________
3. Do you have diabetes?
4. Do you have a history of heart problems or conditions (including a heart murmur or
congenital heart disease)?
5. Do you have a history of respiratory problems or conditions (including asthma)?
6. Are you currently taking a beta-blocker, such as Propranolol, Metoprolol, or Bisoprolol?
For the following questions, select a number from the scale that best describes how typical or
characteristic each of the 12 items is of you. You should make your ratings in terms of how much
you agree or disagree with the statement as a general description of yourself.
0
1
2
3
4
very little
a little
some
much
very much
1. It is important for me not to appear nervous.
2. When I cannot keep my mind on a task, I worry that I might be going crazy.
3. It scares me when my heart beats rapidly.
4. When my stomach is upset, I worry that I might be seriously ill.
5. It scares me when I am unable to keep my mind on a task.
6. When I tremble in the presence of others, I fear what people might think of me.
7. When my chest feels tight, I get scared that I won't be able to breathe properly.
8. When I feel pain in my chest, I worry that I'm going to have a heart attack.
9. I worry that other people will notice my anxiety.
10. When I feel "spacey" or spaced out I worry that I may be mentally ill.
11. It scares me when I blush in front of people.
12. When I notice my heart skipping a beat, I worry that there is something seriously wrong with
me.
13. When I begin to sweat in a social situation, I fear people will think negatively of me.
14. When my thoughts seem to speed up, I worry that I might be going crazy.
15. When my throat feels tight, I worry that I could choke to death.
16. When I have trouble thinking clearly, I worry that there is something wrong with me.
17. I think it would be horrible for me to faint in public.
18. When my mind goes blank, I worry there is something terribly wrong with me.
I am interested in completing an hour-long follow up to this study, whereby I will receive course
credit (if applicable) and a $50 Amazon gift card.
_____No
_____Yes; my contact information is as follows. EMAIL, MOBILE PHONE
From: Gourley, Bethany, "Exploring the relationship between anxiety sensitivity and heart rate
variability" (2019). Master's Theses and Doctoral Dissertations. 982.
https://commons.emich.edu/theses/982
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Appendix B: Demographics Questionnaire
1. Are you a student at Eastern Michigan University?
2. If yes, how many credits are you enrolled in this Semester?
3. If yes, how many college credits have you completed?
4. If no, how did you learn about this study?
5. What is your ethnicity?
a. Not Hispanic or Latino
b. Hispanic or Latino
6. Some people identify themselves as belonging to one or more racial groups. Please
indicate which of the following groups you belong to. Please check all that apply.
a. White or Caucasian
b. Black or African-American
c. Hispanic or Latino
d. American Native/American Indian
e. Alaskan Native
f. Asian
g. Pacific Islander
h. Middle Eastern
i. Other ______
7. What is the economic status of your family household currently? (Please indicate one.)
a. We have barely enough to get by
b. We have enough to get by, but no more
c. We are solidly middle class
d. We have plenty of “extras”
e. We have plenty of “luxuries”
f. Don’t know/unsure/prefer not to say

From: Gourley, Bethany, "Exploring the relationship between anxiety sensitivity and heart rate
variability" (2019). Master's Theses and Doctoral Dissertations. 982.
https://commons.emich.edu/theses/982
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Appendix C: Anxiety Sensitivity Index-3 (ASI-3)
Enter the number from the scale below that best describes how typical or characteristic each of the
18 items is of you, putting the number next to the item. You should make your ratings in terms of
how much you agree or disagree with the statement as a general description of yourself.
0
very little

1
a little

2
some

3
much

4
very much

1. It is important for me not to appear nervous.
2. When I cannot keep my mind on a task, I worry that I might be going crazy.
3. It scares me when my heart beats rapidly.
4. When my stomach is upset, I worry that I might be seriously ill.
5. It scares me when I am unable to keep my mind on a task.
6. When I tremble in the presence of others, I fear what people might think of me.
7. When my chest feels tight, I get scared that I won't be able to breathe properly.
8. When I feel pain in my chest, I worry that I'm going to have a heart attack.
9. I worry that other people will notice my anxiety.
10. When I feel "spacey" or spaced out I worry that I may be mentally ill.
11. It scares me when I blush in front of people.
12. When I notice my heart skipping a beat, I worry that there is something seriously wrong
with me.
13. When I begin to sweat in a social situation, I fear people will think negatively of me.
14. When my thoughts seem to speed up, I worry that I might be going crazy.
15. When my throat feels tight, I worry that I could choke to death.
16. When I have trouble thinking clearly, I worry that there is something wrong with me.
17. I think it would be horrible for me to faint in public.
18. When my mind goes blank, I worry there is something terribly wrong with me.

Taylor, S., Zvolensky, M. J., Cox, B. J., Deacon, B., Heimberg, R. G., Ledley, D. R., &
Cardenas, S. J. (2007). Robust dimensions of anxiety sensitivity: Development and initial
validation of the Anxiety Sensitivity Index-3. Psychological Assessment, 19(2), 176-188.
https://doi.org/10.1037/1040-3590.19.2.176

